Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEVOSAH
2024-514242-36-00Phase 2Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of levosimendan in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Nov 2024; status: authorised.
02
Drugs
levosimendan
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2024-514242-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514242-36-00.